Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended June 2024 as against Rs 2022.54 crore during the previous quarter ended June 2023. Sales rose 6.27% to Rs 12524.51 crore in the quarter ended June 2024 as against Rs 11785.15 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	12524.51	11785.15	6
OPM %	28.80	28.27	-
PBDT	4078.63	3455.33	18
PBT	3423.50	2804.01	22
NP	2835.62	2022.54	40